... offering this superior level of patient-centric service to the industry will address an important industry need: to significantly improve health outcomes while containing costs.
CHARLESTOWN, Ind. (PRWEB) October 19, 2017
Co-located within Knipper’s new state-of-the-art Midwest Distribution Center, KnippeRx maintains a focus on rare disease, orphan and ultra-orphan therapies, and other unique specialty biologics. The mission of KnippeRx is to provide superior ‘speed to therapy’ and exceptional white glove care in a range of therapeutic areas, particularly small population products, which often have specialized handling requirements. Highlights of KnippeRx’s specialty pharmacy services include: distribution and patient dispensing of high-touch, temperature controlled biologic therapies; accelerated patient on-boarding - achieved using cutting edge technology; individually coordinated, personalized delivery of therapy; and the highest quality patient care and clinical support resulting in the best possible health outcomes.
Through its affiliation with J. Knipper and Company, Inc. – the largest supplier of end-to-end pharmaceutical samples management services in the U.S – KnippeRx has been purpose-built on a strong foundation of more than 30 years of healthcare service and excellence. Through this shared DNA, KnippeRx brings the benefit of integrated logistical and operational expertise that is unmatched in the pharma services industry, offering convenience and cost-savings by dispensing and distributing from one centrally located facility in Charlestown, IN. The new pharmacy, located within Knipper’s 313,000 square foot, high-volume facility, is within very close proximity to the UPS World Port in Louisville, KY and just two hours from the FedEx International hub in Indianapolis. The distribution center maintains over 22,000 pallet locations and 5,000 square feet of temperature controlled product storage.
Jim Knipper, owner and CEO of KnippeRx and J. Knipper and Company, Inc. states that, “offering this superior level of patient-centric service to the industry will address an important industry need: to significantly improve health outcomes while containing costs.”
Recie Bomar, General Manager at KnippeRx, also commented, “We are extremely eager to provide these services and partner with patients, providers, manufacturers, and payers to significantly shorten the journey to specialty pharmacy services and achieve unrivaled ‘speed to therapy.’ Through compassionate care, prior authorization expertise, skillful navigation of financial assistance, cutting edge technology, and the highest quality patient support, we are prepared to reduce the typical 14-21 day onboarding process to a mere fraction of that time.”
About KnippeRx Inc.
KnippeRx is a highly nimble, independent specialty pharmacy that was designed to serve the needs of the rare, orphan, and ultra-orphan drug categories and purpose-built to overcome the complex barriers to access, providing the shortest possible path from initiation of script to delivery of essential therapy. As a patient-centric focused pharmacy, KnippeRx provides personalized patient assistance that includes PAP and starter dispensing of specialty therapies, high-touch biologics, and other products requiring temperature control. Our clear concentration enables us to provide exceptional services to manufacturers, patients, providers, and payers—in a manner never before offered in the specialty care environment.
KnippeRx uniquely addresses the industry’s expressed need for increased speed to therapy and improved patient outcomes. We call it CARE. AT THE SPEED OF NEED.
For more information, visit http://www.knipperx.com.
About J. Knipper and Company, Inc.
Founded in 1986, J. Knipper and Company, Inc., provides the healthcare industry with solutions in direct marketing, sampling, compliance, information technology and sales force productivity. Going beyond its roots in direct marketing fulfillment and sample distribution, J. Knipper and Company continues to offer innovative solutions to brand marketing and sales force challenges as well as robust and comprehensive compliance data services.
The Company has invested considerably in its physical and data infrastructure over the years. Knipper now maintains over 600,000 square feet of facilities, including significant storage capacity for refrigerated product and controlled substances, along with an advanced data center protected for the secure and safe management of client data and application services. J. Knipper and Company has become the largest provider of sample management services in the US and is one of a handful of companies approved as an American Medical Association Database licensee.
For more information, visit http://www.knipper.com.
